Trial Profile
Phase I trial of RDEA 427
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 13 Mar 2014
Price :
$35
*
At a glance
- Drugs RDEA 427 (Primary)
- Indications HIV infections
- Focus Adverse reactions
- Sponsors Ardea Biosciences
- 21 Nov 2008 Added subject type, as reported by an Ardea Biosciences media release.
- 02 Apr 2008 New trial record.